Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size

Featured Research

What can we learn by studying exercise and Parkinson's? PDF-funded researcher Kristen Pickett, Ph.D., is using magnetic resonance imaging to help find answers to improve life for people with PD.

Learn More

PDF Grant Programs

Are you interested in furthering Parkinson's science? View PDF's open grant programs.

Learn More


Causes and Pathology

PDF's targeted PubMed search provides you with access to journal articles from the last 90 days that may be pertinent to Parkinson's disease research. 

Not what you're looking for? Do you need informational publications about Parkinson's targeted for people living with Parkinson's, caregivers and family members?  Please browse PDF's educational materials and programs - which are all available electronically or in print.  Order for yourself, a loved one or in bulk for your patients or support group.


Prevención de Caídas

1) PDF Research Centers

Columbia


http://www.ncbi.nlm.nih.gov/pubmed?term=Columbia%5BAD%5D%20AND%20(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(alcalay%20rn%5Bau%5D%20OR%20burke%20rb%5BAU%5D%20OR%20clark%20l%5BAU%5D%20OR%20fahn%20s%5BAU%5D%20OR%20Ford%20B%5BAU%5D%20OR%20greene%20l%5BAU%5D%20OR%20greene%20p%5BAU%5D%20OR%20kuo%20sh%5Bau%5D%20OR%20louis%20e%5BAU%5D%20OR%20marder%20k%5BAU%5D%20OR%20mazzoni%20p%5BAU%5D%20OR%20przedborski%20s%5BAU%5D%20OR%20pullman%20s%5BAU%5D%20OR%20stern%20y%5BAU%5D%20OR%20sulzer%20d%5BAU%5D%20OR%20vonsattel%5BAU%5D%20OR%20waters%20c%5BAU%5D%20OR%20yamamoto%20a%5BAU%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Rush


http://www.ncbi.nlm.nih.gov/pubmed?term=Rush%5BAD%5D%20AND%20(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Barton%20B%5BAU%5D%20OR%20Bernard%20B%5BAU%5D%20OR%20Comella%20C%5BAU%5D%20OR%20Goldman%20J%5BAU%5D%20OR%20Goetz%20C%5BAU%5D%20OR%20Hall%20D%5BAU%5D%20OR%20Kompoliti%20K%5BAU%5D%20OR%20Kordower%20J%5BAU%5D%20OR%20Shannon%20K%5BAU%5D%20Stebbins%20G%5BAU%5D%20OR%20Verhagen%20L%5BAU%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Cornell


http://www.ncbi.nlm.nih.gov/pubmed?term=Cornell%5BAD%5D%20AND%20(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Beal%20MF%5BAU%5D%20OR%20Henchcliffe%20c%5BAU%5D%20OR%20Nirenberg%20m%5BAU%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

PARKINSON’S DISEASE TOPIC AREAS
Understanding Parkinson’s


Motor Symptoms
    

General

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(motor%5BAll%20Fields%5D%20AND%20(%22diagnosis%22%5BSubheading%5D%20OR%20%22diagnosis%22%5BAll%20Fields%5D%20OR%20%22symptoms%22%5BAll%20Fields%5D%20OR%20%22diagnosis%22%5BMeSH%20Terms%5D%20OR%20%22symptoms%22%5BAll%20Fields%5D))%20NOT%20(%E2%80%9Cnon-motor%E2%80%9D%5BTIAB%5D%20OR%20%E2%80%9Cnon%20motor%E2%80%9D%5BTIAB%5D%20OR%20%E2%80%9Cnonmotor%E2%80%9D%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)%20AND%20(%22review%22%5BPublication%20Type%5D%20OR%20%22review%20literature%20as%20topic%22%5BMeSH%20Terms%5D%20OR%20%22review%22%5BAll%20Fields%5D)

    Balance and Falls

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Balance%20%5BTIAB%5D%20OR%20Falls%20%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)
    Gait or Freezing

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Gait%5BTIAB%5D%20OR%20Freezing%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

    Dyskinesia
    Nonmotor Symptoms and Complications

    General
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(%E2%80%9Cnon-motor%E2%80%9D%5BTIAB%5D%20OR%20%E2%80%9Cnon%20motor%E2%80%9D%5BTIAB%5D%20OR%20%E2%80%9Cnonmotor%E2%80%9D%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Pain
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(pain%5BTI%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Sleep and Fatigue/ REM Behavior Sleep Disorder

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Sleep%5BTIAB%5D%20OR%20Fatigue%5BTIAB%5D%20OR%20%E2%80%9DREM%20behavior%20disorder%E2%80%9D%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

    Gastrointestinal and Urinary Function
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Gastrointestinal%5BTIAB%5D%20OR%20Urinary%20%5BTIAB%5D%20OR%20%E2%80%9CBowel%20dysfunction%E2%80%9D%5BTIAB%5D%20OR%20%E2%80%9CBladder%20dysfunction%E2%80%9D%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

    Cognition and Hallucination

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(cognition%5BTIAB%5D%20OR%20hallucination%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Impulse Control Disorder

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Impulse%20Control%20Disorder%5BTIAB%5D%20OR%20ICD%5BTIAB%5D%20OR%20gambling%5BTIAB%5D%20OR%20shopping%5BTIAB%5D%20OR%20hypersexuality%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Vision/Visual hallucination

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Blurred%20vision%5BTIAB%5D%20OR%20Photophobia%5BTIAB%5D%20OR%20Asthenopia%5BTIAB%5D%20OR%20Double%20vision%5BTIAB%5D%20OR%20Visual%20hallucination%5BTIAB%5D%20OR%20spatial%20relations%5BTIAB%5D%20OR%20color%20perception%5BTIAB%5D)

Oral
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(dental%5BTIAB%5D%20OR%20dysphagia%5BTIAB%5D%20OR%20burning%20mouth%5BTIAB%5D%20OR%20drooling%5BTIAB%5D%20OR%20teeth%5BTIAB%5D%20or%20sialorrhea%5BTIAB%5D%20OR%20gingiva%5BTIAB%5D%20OR%20periodontal%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Speech
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(speech%5BTIAB%5D%20OR%20hypophonia%5BTIAB%5D%20OR%20verbal%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Orthostatic Hypotension
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(Orthostatic%20Hypotension%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Etiology/Pathology

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(etiology%5BTIAB%5D%20OR%20pathology%5BTIAB%5D%20OR%20disease%20model%5BTIAB%5D)%20AND%20(%22review%22%5BPublication%20Type%5D%20OR%20%22review%20literature%20as%20topic%22%5BMeSH%20Terms%5D%20OR%20%22review%22%5BAll%20Fields%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Imaging Studies
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(imaging%5BTIAB%5D%20OR%20MRI%5BTIAB%5D%20OR%20fMRI%5BTIAB%5D%20OR%20PET%5BTIAB%5D%20OR%20SPECT%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)


Clinical Studies

General
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20Clinical%20Trial%5Bptyp%5D%20AND%20(%22last%20180%20days%22%5BDP%5D)

Genetics

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(%22genetics%22%5BSubheading%5D%20OR%20%22genetics%22%5BAll%20Fields%5D%20OR%20%22genetics%22%5BMeSH%20Terms%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)


Treating Parkinson’s

Current and potential medications/Therapies http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(treatment%5BTI%5D%20OR%20therapy%5BTI%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

    Surgical Treatments
        
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(stem%20cell%5BTIAB%5D)%20AND%20(treatment%5BTIAB%5D%20OR%20therapy%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)
    
Gene Therapy
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(gene%20therapy%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Deep Brain Stimulation
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(gene%20therapy%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Physical, Occupational and Speech Therapy
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(physical%20therapy%5BTIAB%5D%20OR%20occupational%20therapy%5BTIAB%5D%20OR%20speech%20therapy%5BTIAB%5D%20OR%20rehabilitation%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Nutrition

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(diet%5Btiab%5D%20OR%20nutrition%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Exercise
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(exercise%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Art and Music

http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(art%5BTIAB%5D%20OR%20painting%5BTIAB%5D%20OR%20creativity%5BTIAB%5DOR%20music%5BTIAB%5D)%20NOT%20%E2%80%9Cstate%20of%20the%20art%E2%80%9D%5BTIAB%5D%20AND%20(%22last%2090%20days%22%5BDP%5D)


Complementary and Alternative Therapies
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(complementary%20therapy%5BTIAB%5D%20OR%20alternative%20therapy%5BTIAB%5D%20OR%20Adjunct%20therapy%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)


Living with a Parkinson’s Diagnosis

Driving
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(driving%5BTIAB%5D%20AND%20(car%5BTIAB%5D%20OR%20automobile%5BTIAB%5D))

Hospitalization


http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(hospitalization%5BTIAB%5D)%20AND%20(%22last%2090%20days%22%5BDP%5D)

Care giving
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(caregiver%5BTIAB%5D%20OR%20caregiving%5BTIAB%5D%20OR%20hygiene%5BTIAB%5D%20OR%20dressing%5BTIAB%5D%20OR%20support%20group%5BTIAB%5D%20OR%20health%20care%5BTIAB%5D%20OR%20home%20care%5BTIAB%5D%20OR%20helpline%5BTIAB%5D)AND%20(%22last%2090%20days%22%5BDP%5D)

Hospice/End of Life/Palliative Care
http://www.ncbi.nlm.nih.gov/pubmed?term=(Parkinson%5BTIAB%5D%20OR%20Parkinson%E2%80%99s%20disease%5BTIAB%5D)%20AND%20(hospice%5BTI%5D%20OR%20%E2%80%9Cend%20of%20life%E2%80%9D%5BTI%5D%20OR%20palliative%5BTI%5D)

There was an error retrieving the document. Please try again.

Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats.
Kun-Cheng Liu, Jun-Yi Li, Hui-Hui Tan, Cheng-Xue Du, Wen Xie, Yu-Ming Zhang, Wei-Lin Ma, Li Zhang
Neuropharmacology 2015 Apr; 95:290-298
PMID: 25863121 [PubMed - as supplied by publisher]


Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins.
Sunny Rae Slone, Nicholas Lavalley, Michael McFerrin, Bing Wang, Talene Alene Yacoubian
Neurobiol Dis 2015 Apr; 79:1-13
PMID: 25862939 [PubMed - as supplied by publisher]


Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3? pathways.
Lun Qing Zhang, Fei Sa, Cheong Meng Chong, Ying Wang, Zhong Yan Zhou, Chuen Chung Chang, Shun Wan Chan, Pui Man Hoi, Simon Ming Yuen Lee
J Ethnopharmacol 2015 Apr;
PMID: 25934514 [PubMed - as supplied by publisher]


Hydrogen sulfide in pharmacology and medicine - An update.
Jerzy Be?towski
Pharmacol Rep 2015 Jun; 67(3):647-658
PMID: 25933982 [PubMed - as supplied by publisher]


DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients.
Shahidee Zainal Abidin, Eng Liang Tan, Soon-Choy Chan, Ameerah Jaafar, Alex Xuen Lee, Mohd Hamdi Noor Abd Hamid, Nor Azian Abdul Murad, Nur Fadlina Pakarul Razy, Shahrul Azmin, Azlina Ahmad Annuar, Shen Yang Lim, Pike-See Cheah, King-Hwa Ling, Norlinah Mohamed Ibrahim
BMC Neurol 2015; 15(1):59
PMID: 25896831 [PubMed - as supplied by publisher]


TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis.
Takahiro Takeda, Mutsumi Iijima, Toshiki Uchihara, Takashi Ohashi, Danielle Seilhean, Charles Duyckaerts, Shinichiro Uchiyama
J Neuropathol Exp Neurol 2015 Apr;
PMID: 25933387 [PubMed - as supplied by publisher]


Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
Vincent A Jourdain, Nicolas Morin, Laurent Grégoire, Marc Morissette, Thérèse Di Paolo
J Neurosurg 2015 May; :1-11
PMID: 25932606 [PubMed - as supplied by publisher]


Effects of impaired membrane interactions on ?-synuclein aggregation and neurotoxicity.
Daniel Ysselstein, Mehul Joshi, Vartika Mishra, Amy M Griggs, Josephat M Asiago, George P McCabe, Lia A Stanciu, Carol Beth Post, Jean-Christophe Rochet
Neurobiol Dis 2015 Apr;
PMID: 25931201 [PubMed - as supplied by publisher]


Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism.
Gabriela da Rocha Lindner, Danúbia Bonfanti Santos, Dirleise Colle, Eduardo Luiz Gasnhar Moreira, Rui Daniel Prediger, Marcelo Farina, Najeh Maissar Khalil, Rubiana Mara Mainardes
Nanomedicine (Lond) 2015 Apr; 10(7):1127-38
PMID: 25929569 [PubMed - as supplied by publisher]


Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.
Richard A Armstrong, Nigel J Cairns
J Neural Transm 2015 May;
PMID: 25929331 [PubMed - as supplied by publisher]


Transcranial Direct Current Stimulation Ameliorates Behavioral Deficits and Reduces Oxidative Stress in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Model of Parkinson's Disease.
Chengbiao Lu, Yun Wei, Rui Hu, Yong Wang, Kun Li, Xiaoli Li
Neuromodulation 2015 May;
PMID: 25929279 [PubMed - as supplied by publisher]


Phytic acid attenuates inflammatory responses and the levels of NF?B and p-ERK in MPTP-induced Parkinson's disease model of mice.
Yuqiang Lv, Zheng Zhang, Lin Hou, Li Zhang, Jinyu Zhang, Yuehua Wang, Cun Liu, Pingping Xu, Lu Liu, Xiaoying Gai, Tingxiu Lu
Neurosci Lett 2015 Apr;
PMID: 25929185 [PubMed - as supplied by publisher]


The A53E ?-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture.
Nicola J Rutherford, Benoit I Giasson
Neurosci Lett 2015 Apr; 597:43-48
PMID: 25892596 [PubMed - as supplied by publisher]


Synthetic and Natural Inhibitors of Phospholipases A2: Their Importance for Understanding and Treatment of Neurological Disorders.
Wei-Yi Ong, Tahira Farooqui, George Kokotos, Akhlaq A Farooqui
ACS Chem Neurosci 2015 May;
PMID: 25891385 [PubMed - as supplied by publisher]


The role of the acidic domain of ?-synuclein in amyloid fibril formation: a molecular dynamics study.
SeongByeong Park, Jeseong Yoon, Soonmin Jang, Kyunghee Lee, Seokmin Shin
J Biomol Struct Dyn 2015 May; :1-8
PMID: 25869255 [PubMed - as supplied by publisher]


A tripeptide isolated from Bothrops atrox venom has neuroprotective and neurotrophic effects on a cellular model of Parkinson's disease.
N M Martins, N A G Santos, M A Sartim, A C O Cintra, S V Sampaio, A C Santos
Chem Biol Interact 2015 Apr; 235:10-16
PMID: 25868679 [PubMed - as supplied by publisher]


Roles of Ca(2+)/calmodulin-dependent protein kinase II in subcellular expression of striatal N-Methyl-D-aspartate receptors in l-3, 4-dihydroxyphenylalanine-induced dyskinetic rats.
Jing Gan, Chen Qi, Zhenguo Liu
Drug Des Devel Ther 2015 ; 9:2119-28
PMID: 25926720 [PubMed - as supplied by publisher]


Remote His50 Acts as a Coordination Switch in the High-Affinity N-Terminal Centered Copper(II) Site of ?-Synuclein.
Riccardo De Ricco, Daniela Valensin, Simone Dell'Acqua, Luigi Casella, Pierre Dorlet, Peter Faller, Christelle Hureau
Inorg Chem 2015 Apr;
PMID: 25926427 [PubMed - as supplied by publisher]


Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells.
Xi-Lin Lu, Yue-Hao Lin, Qi Wu, Feng-Juan Su, Cheng-Hui Ye, Lei Shi, Bai-Xuan He, Fei-Wen Huang, Zhong Pei, Xiao-Li Yao
BMC Complement Altern Med 2015 Apr; 15(1):137
PMID: 25925762 [PubMed - as supplied by publisher]


Modulation of endoplasmic reticulum stress: an opportunity to prevent neurodegeneration?
A I Placido, Cmf Pereira, A I Duarte, E Candeias, S C Correia, C Carvalho, S Cardoso, C R Oliveira, P I Moreira
CNS Neurol Disord Drug Targets 2015 Apr;
PMID: 25921746 [PubMed - as supplied by publisher]


CypD: The Key to the Death Door.
S M Fayaz, Y Raj Vijay, G K Rajanikant
CNS Neurol Disord Drug Targets 2015 Apr;
PMID: 25921742 [PubMed - as supplied by publisher]


Relating gas phase to solution conformations: Lessons from disordered proteins.
Rebecca Beveridge, Ashley S Phillips, Laetitia Denbigh, Hassan M Saleem, Cait E MacPhee, Perdita E Barran
Proteomics 2015 Apr;
PMID: 25920945 [PubMed - as supplied by publisher]


Hypochondriasis as an early manifestation of dementia with Lewy bodies: an autopsied case report.
Hiroshige Fujishiro, Shuji Iritani, Hirotaka Sekiguchi, Chikako Habuchi, Youta Torii, Shinji Matsunaga, Norio Ozaki, Mari Yoshida, Kiyoshi Fujita
Psychogeriatrics 2015 Apr;
PMID: 25919332 [PubMed - as supplied by publisher]


Mitochondrial Dysfunction and ?-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
Michela Zaltieri, Francesca Longhena, Marina Pizzi, Cristina Missale, PierFranco Spano, Arianna Bellucci
Parkinsons Dis 2015 ; 2015:108029
PMID: 25918668 [PubMed - as supplied by publisher]


Targeting ?-arrestin2 in the treatment of l-DOPA-induced dyskinesia in Parkinson's disease.
Nikhil M Urs, Simone Bido, Sean M Peterson, Tanya L Daigle, Caroline E Bass, Raul R Gainetdinov, Erwan Bezard, Marc G Caron
Proc Natl Acad Sci U S A 2015 Apr;
PMID: 25918399 [PubMed - as supplied by publisher]


Controlled and impaired mitochondrial quality in neurons: molecular Physiology and prospective Pharmacology.
Ivana Matic, Daniela Strobbe, Michele Frison, Michelangelo Campanella
Pharmacol Res 2015 Apr;
PMID: 25917207 [PubMed - as supplied by publisher]


Animal models for prion-like diseases.
Natalia Fernández-Borges, Hasier Eraña, Vanesa Venegas, Saioa R Elezgarai, Chafik Harrathi, Joaquín Castilla
Virus Res 2015 Apr;
PMID: 25907990 [PubMed - as supplied by publisher]


Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
C Fidalgo, W K D Ko, E Tronci, Q Li, R Stancampiano, Q Chuan, E Bezard, M Carta
Neuroscience 2015 Apr;
PMID: 25907446 [PubMed - as supplied by publisher]


Posttranslational Modifications and Clearing of ?-Synuclein Aggregates in Yeast.
Blagovesta Popova, Alexandra Kleinknecht, Gerhard H Braus
Biomolecules 2015; 5(2):617-634
PMID: 25915624 [PubMed - as supplied by publisher]


Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases.
Miguel Chin-Chan, Juliana Navarro-Yepes, Betzabet Quintanilla-Vega
Front Cell Neurosci 2015 ; 9:124
PMID: 25914621 [PubMed - as supplied by publisher]


Cabergoline protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture.
J Meinel, K Radad, W-D Rausch, H Reichmann, G Gille
Folia Neuropathol 2015 ; 53(1):29-40
PMID: 25909873 [PubMed - as supplied by publisher]


Association of the rs1801133 variant in the MTHFR gene and sporadic Parkinson's disease.
S García, Rm Coral-Vázquez, M P Gallegos-Arreola, L A Montes-Almanza, P Canto, F A García-Martínez, G Chavira-Hernández, C Palma-Flores, L Dávila-Maldonado, C F Cuevas-García, L B López Hernández
Folia Neuropathol 2015 ; 53(1):24-8
PMID: 25909872 [PubMed - as supplied by publisher]


Blood metal levels and related antioxidant enzyme activities in patients with ataxia telangiectasia.
Stefania Squadrone, Paola Brizio, Cecilia Mancini, Elisa Pozzi, Simona Cavalieri, Maria Cesarina Abete, Alfredo Brusco
Neurobiol Dis 2015 Apr;
PMID: 25882094 [PubMed - as supplied by publisher]


Oligomers of Parkinson's disease-related alpha-synuclein mutants have similar structures but distinctive membrane permeabilization properties.
Anja N D Stefanovic, Saskia Lindhoud, Slav A Semerdzhiev, Mireille M A E Claessens, Vinod Subramaniam
Biochemistry 2015 Apr;
PMID: 25909158 [PubMed - as supplied by publisher]


Progressive decline of glucocerebrosidase in aging and Parkinson's disease.
Emily M Rocha, Gaynor A Smith, Eric Park, Hongmei Cao, Eilish Brown, Penelope Hallett, Ole Isacson
Ann Clin Transl Neurol 2015 Apr; 2(4):433-8
PMID: 25909088 [PubMed - as supplied by publisher]


Variants associated with Gaucher disease in multiple system atrophy.
Jun Mitsui, Takashi Matsukawa, Hidenao Sasaki, Ichiro Yabe, Masaaki Matsushima, Alexandra Dürr, Alexis Brice, Hiroshi Takashima, Akio Kikuchi, Masashi Aoki, Hiroyuki Ishiura, Tsutomu Yasuda, Hidetoshi Date, Budrul Ahsan, Atsushi Iwata, Jun Goto, Yaeko Ichikawa, Yasuo Nakahara, Yoshio Momose, Yuji Takahashi, Kenju Hara, Akiyoshi Kakita, Mitsunori Yamada, Hitoshi Takahashi, Osamu Onodera, Masatoyo Nishizawa, Hirohisa Watanabe, Mizuki Ito, Gen Sobue, Kinya Ishikawa, Hidehiro Mizusawa, Kazuaki Kanai, Takamichi Hattori, Satoshi Kuwabara, Kimihito Arai, Shigeru Koyano, Yoshiyuki Kuroiwa, Kazuko Hasegawa, Tatsuhiko Yuasa, Kenichi Yasui, Kenji Nakashima, Hijiri Ito, Yuishin Izumi, Ryuji Kaji, Takeo Kato, Susumu Kusunoki, Yasushi Osaki, Masahiro Horiuchi, Tomoyoshi Kondo, Shigeo Murayama, Nobutaka Hattori, Mitsutoshi Yamamoto, Miho Murata, Wataru Satake, Tatsushi Toda, Alessandro Filla, Thomas Klockgether, Ullrich Wüllner, Garth Nicholson, Sid Gilman, Caroline M Tanner, Walter A Kukull, Mathew B Stern, Virginia M-Y Lee, John Q Trojanowski, Eliezer Masliah, Phillip A Low, Paola Sandroni, Laurie J Ozelius, Tatiana Foroud, Shoji Tsuji
Ann Clin Transl Neurol 2015 Apr; 2(4):417-26
PMID: 25909086 [PubMed - as supplied by publisher]


Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
Yong-Fei Zhao, Qiong Zhang, Jian-Ying Xi, Yan-Hua Li, Cun-Gen Ma, Bao-Guo Xiao
J Neurol Sci 2015 Mar;
PMID: 25908255 [PubMed - as supplied by publisher]


The Potential Application of Mitochondrial Medicine in Toxicologic Poisoning.
David H Jang, Joshua W Lampe, Lance B Becker
J Med Toxicol 2015 Apr;
PMID: 25907836 [PubMed - as supplied by publisher]


Protein Interacting with C-Kinase 1 Deficiency Impairs Glutathione Synthesis and Increases Oxidative Stress via Reduction of Surface Excitatory Amino Acid Carrier 1.
Ya-Nan Wang, Liang Zhou, Yun-Hong Li, Zhen Wang, Ying-Cong Li, Ya-Wen Zhang, Yin Wang, Gang Liu, Ying Shen
J Neurosci 2015 Apr; 35(16):6429-43
PMID: 25904794 [PubMed - as supplied by publisher]


Parkinson's disease.
Lorraine V Kalia, Anthony E Lang
Lancet 2015 Apr;
PMID: 25904081 [PubMed - as supplied by publisher]


Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats.
Andrea Ferrigno, Mariapia Vairetti, Giulia Ambrosi, Vittoria Rizzo, Plinio Richelmi, Fabio Blandini, Marie-Therese Armentero
Clin Exp Pharmacol Physiol 2015 Apr;
PMID: 25904005 [PubMed - as supplied by publisher]


Activation of Autophagy Contributes to the Angiotensin II-Triggered Apoptosis in a Dopaminergic Neuronal Cell Line.
Qing Gao, Teng Jiang, Hong-Rui Zhao, Liang Wu, You-Yong Tian, Zhou Ou, Li Zhang, Yang Pan, Jie Lu, Ying-Dong Zhang
Mol Neurobiol 2015 Apr;
PMID: 25902863 [PubMed - as supplied by publisher]


Direct Detection of ?-Synuclein Dimerization Dynamics: Single-Molecule Fluorescence Analysis.
Zhengjian Lv, Alexey V Krasnoslobodtsev, Yuliang Zhang, Daniel Ysselstein, Jean-Christophe Rochet, Scott C Blanchard, Yuri L Lyubchenko
Biophys J 2015 Apr; 108(8):2038-47
PMID: 25902443 [PubMed - as supplied by publisher]


Effects of cardiolipin on membrane morphology: a langmuir monolayer study.
Minh Dinh Phan, Kwanwoo Shin
Biophys J 2015 Apr; 108(8):1977-86
PMID: 25902437 [PubMed - as supplied by publisher]


The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms.
Jin-Sung Park, Nicholas F Blair, Carolyn M Sue
Mov Disord 2015 Apr;
PMID: 25900096 [PubMed - as supplied by publisher]


Anxiety provoked gait changes are selectively dopa-responsive in parkinson's disease.
Kaylena A Ehgoetz Martens, Colin G Ellard, Quincy J Almeida
Eur J Neurosci 2015 Apr;
PMID: 25899750 [PubMed - as supplied by publisher]


Cellular processes associated with LRRK2 function and dysfunction.
Rebecca Wallings, Claudia Manzoni, Rina Bandopadhyay
FEBS J 2015 Apr;
PMID: 25899482 [PubMed - as supplied by publisher]


Parkinson's disease: fetal cell or stem cell-derived treatments.
Arnar Astradsson, Tipu Z Aziz
BMJ Clin Evid 2015 ; 2015
PMID: 25898159 [PubMed - as supplied by publisher]


Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study.
Cui-Tao Lu, Rong-Rong Jin, Yi-Na Jiang, Qian Lin, Wen-Ze Yu, Kai-Li Mao, Fu-Rong Tian, Ya-Ping Zhao, Ying-Zheng Zhao
Drug Des Devel Ther 2015 ; 9:1955-62
PMID: 25897205 [PubMed - as supplied by publisher]


Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Keon Sung Shin, Ting Ting Zhao, Keun Hong Park, Hyun Jin Park, Bang Yeon Hwang, Chong Kil Lee, Myung Koo Lee
BMC Neurosci 2015 Apr; 16(1):23
PMID: 25896846 [PubMed - as supplied by publisher]


Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
Fabiana Miraglia, Laura Betti, Lionella Palego, Gino Giannaccini
Cent Nerv Syst Agents Med Chem 2015 Apr;
PMID: 25896035 [PubMed - as supplied by publisher]


Neuroimaging in Parkinson's disease: a future perspective.
David J Brooks
Neurodegener Dis Manag 2015 Apr; 5(2):105-8
PMID: 25894874 [PubMed - as supplied by publisher]


Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.
Sandeep Vasant More, Dong-Kug Choi
Mol Neurodegener 2015 ; 10(1):17
PMID: 25888232 [PubMed - as supplied by publisher]


PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases.
Sara Martire, Luciana Mosca, Maria d'Erme
Mech Ageing Dev 2015 Apr; 146-148C:53-64
PMID: 25881554 [PubMed - as supplied by publisher]


Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice.
Shinki Murakami, Ikuko Miyazaki, Ko Miyoshi, Masato Asanuma
Neurochem Res 2015 Apr;
PMID: 25894684 [PubMed - as supplied by publisher]


New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation.
Dorit Trudler, Yuval Nash, Dan Frenkel
J Neural Transm 2015 Apr;
PMID: 25894287 [PubMed - as supplied by publisher]


?-Synuclein pathology accumulates in sacral spinal visceral sensory pathways.
Veronique G VanderHorst, Tamara Samardzic, Clifford B Saper, Matthew P Anderson, Sukriti Nag, Julie A Schneider, David A Bennett, Aron S Buchman
Ann Neurol 2015 Apr;
PMID: 25893830 [PubMed - as supplied by publisher]


Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death.
Shaosong Yang, Li Gao, Fangfang Lu, Bao Wang, Fei Gao, Gang Zhu, Zhibiao Cai, Juan Lai, Qian Yang
J Neuroinflammation 2015 ; 12(1):33
PMID: 25890150 [PubMed - as supplied by publisher]


The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.
Gerwyn Morris, Michael Berk
BMC Med 2015 ; 13:68
PMID: 25889215 [PubMed - as supplied by publisher]


LRRK2 mutations and neurotoxicant susceptibility.
Jang-Won Lee, Jason R Cannon
Exp Biol Med (Maywood) 2015 Apr;
PMID: 25888648 [PubMed - as supplied by publisher]


Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
Wei Xiang, Stefanie Menges, Johannes Cm Schlachetzki, Holger Meixner, Anna-Carin Hoffmann, Ursula Schlötzer-Schrehardt, Cord-Michael Becker, Jürgen Winkler, Jochen Klucken
Mol Neurodegener 2015 ; 10(1):8
PMID: 25886189 [PubMed - as supplied by publisher]


Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies.
Anthony Samsel, Stephanie Seneff
Surg Neurol Int 2015 ; 6:45
PMID: 25883837 [PubMed - as supplied by publisher]


Protective effects of a polysaccharide from Spirulina platensis on dopaminergic neurons in an MPTP-induced Parkinson's disease model in C57BL/6J mice.
Fang Zhang, Jian Lu, Ji-Guo Zhang, Jun-Xia Xie
Neural Regen Res 2015 Feb; 10(2):308-13
PMID: 25883632 [PubMed - as supplied by publisher]


Activation of NMDA receptor by elevated homocysteine in chronic liver disease contributes to encephalopathy.
Sabanum Choudhury, Anupom Borah
Med Hypotheses 2015 Apr;
PMID: 25881985 [PubMed - as supplied by publisher]


Overexpression of 17?-hydroxysteroid dehydrogenase type 10 increases pheochromocytoma cell growth and resistance to cell death.
Emily A Carlson, Rebecca T Marquez, Fang Du, Yongfu Wang, Liang Xu, Shirley ShiDu Yan
BMC Cancer 2015 ; 15:166
PMID: 25879199 [PubMed - as supplied by publisher]


Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.
Davide Chiasserini, Silvia Paciotti, Paolo Eusebi, Emanuele Persichetti, Anna Tasegian, Marzena Kurzawa-Akanbi, Patrick F Chinnery, Christopher M Morris, Paolo Calabresi, Lucilla Parnetti, Tommaso Beccari
Mol Neurodegener 2015 Mar; 10(1):15
PMID: 25881142 [PubMed - as supplied by publisher]


Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review.
Myria Petrou, Ben A Dwamena, Bradley R Foerster, Mark P MacEachern, Nicolaas I Bohnen, Martijn Ltm Müller, Roger L Albin, Kirk A Frey
Mov Disord 2015 Apr;
PMID: 25879534 [PubMed - as supplied by publisher]


RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.
Núria Martín-Flores, Joan Romaní-Aumedes, Laura Rué, Mercè Canal, Phil Sanders, Marco Straccia, Nicholas D Allen, Jordi Alberch, Josep M Canals, Esther Pérez-Navarro, Cristina Malagelada
Mol Neurobiol 2015 Apr;
PMID: 25876513 [PubMed - as supplied by publisher]


Neuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson's Disease.
Jinghua Liu, Arjun H Banskota, Alan T Critchley, Jeff Hafting, Balakrishnan Prithiviraj
Mar Drugs 2015 ; 13(4):2250-66
PMID: 25874922 [PubMed - as supplied by publisher]


Acrylamide induces locomotor defects and degeneration of dopamine neurons in Caenorhabditis elegans.
Jia Li, Dan Li, Yongsheng Yang, Tiantian Xu, Ping Li, Defu He
J Appl Toxicol 2015 Apr;
PMID: 25876170 [PubMed - as supplied by publisher]


The Interplay between Alpha-Synuclein Clearance and Spreading.
Tomás Lopes da Fonseca, Anna Villar-Piqué, Tiago Fleming Outeiro
Biomolecules 2015; 5(2):435-471
PMID: 25874605 [PubMed - as supplied by publisher]


Loss of hfe function reverses impaired recognition memory caused by olfactory manganese exposure in mice.
Qi Ye, Jonghan Kim
Toxicol Res 2015 Mar; 31(1):17-23
PMID: 25874029 [PubMed - as supplied by publisher]


Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated ?-synuclein.
Eduard Bentea, Anke Van der Perren, Joeri Van Liefferinge, Anissa El Arfani, Giulia Albertini, Thomas Demuyser, Ellen Merckx, Yvette Michotte, Ilse Smolders, Veerle Baekelandt, Ann Massie
Front Behav Neurosci 2015 ; 9:68
PMID: 25873870 [PubMed - as supplied by publisher]


Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly.
Julia Zaccai, Carol Brayne, Fiona E Matthews, Paul G Ince,
Alzheimers Res Ther 2015 ; 7(1):19
PMID: 25870655 [PubMed - as supplied by publisher]


Glutathione S-transferase T1 and M1 null genotypes and Parkinson's disease risk: evidence from an updated meta-analysis.
Hongzhou Liu, Jie Peng, Jiajia Gao, Fang Zheng, Chaorong Tie
Neurol Sci 2015 Apr;
PMID: 25868597 [PubMed - as supplied by publisher]


The prion hypothesis of Parkinson's disease.
Yaping Chu, Jeffrey H Kordower
Curr Neurol Neurosci Rep 2015 May; 15(5):28
PMID: 25868519 [PubMed - as supplied by publisher]


CK2beta promotes Pink1/Parkin-mediated MIRO1 degradation].
Chenliang Zhang, Siyue Qin, Chang'an Jiang
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2014 Dec; 31(6):1310-5
PMID: 25868250 [PubMed - as supplied by publisher]


Delayed emergence from general anesthesia in a dementia patient with Lewy bodies].
Sawako Takebe, Kazuyoshi Inoue, Hiroyuki Kawanishi, Hitoshi Nakamura, Ai Ohnishi, Junji Ohnishi, Yuichi Yatsu, Akihiro Nagai, Rikiya Matsuda, Akihito Hirasaki
Masui 2015 Jan; 64(1):81-3
PMID: 25868207 [PubMed - as supplied by publisher]


Rapid Eye Movement Sleep Behavior Disorder and Neurodegenerative Disease.
Michael Joseph Howell, Carlos Hugh Schenck
JAMA Neurol 2015 Apr;
PMID: 25867792 [PubMed - as supplied by publisher]


High levels of DJ-1 protein and isoelectric point 6.3 isoform in the serum of breast cancer patients.
Takahiko Kawate, Keiichi Iwaya, Kayoko Koshikawa, Tomoyuki Moriya, Tamio Yamasaki, Sho Hasegawa, Hiroshi Kaise, Tomoyuki Fujita, Hirotaka Matsuo, Takahiro Nakamura, Takashi Ishikawa, Sadayuki Hiroi, Sanae M M Iguchi-Ariga, Hiroyoshi Ariga, Keiichi Murota, Minoru Fujimori, Junji Yamamoto, Osamu Matsubara, Norio Kohno
Cancer Sci 2015 Apr;
PMID: 25867058 [PubMed - as supplied by publisher]


Could ?-Synuclein Amyloid-Like Aggregates Trigger a Prionic Neuronal Invasion?
Maria Antònia Busquets, Alba Espargaró, Joan Estelrich, Raimon Sabate
Biomed Res Int 2015; 2015:172018
PMID: 25866763 [PubMed - as supplied by publisher]


Chaperoned amyloid proteins for immune manipulation: ?-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype.
Adahir Labrador-Garrido, Marta Cejudo-Guillén, Rebecca Klippstein, Erwin J De Genst, Laura Tomas-Gallardo, María M Leal, Javier Villadiego, Juan J Toledo-Aral, Christopher M Dobson, David Pozo, Cintia Roodveldt
Immun Inflamm Dis 2014 Dec; 2(4):226-38
PMID: 25866630 [PubMed - as supplied by publisher]


Reactivity of copper-?-synuclein peptide complexes relevant to Parkinson's disease.
Simone Dell'Acqua, Valentina Pirota, Cecilia Anzani, Michela M Rocco, Stefania Nicolis, Daniela Valensin, Enrico Monzani, Luigi Casella
Metallomics 2015 Apr;
PMID: 25865825 [PubMed - as supplied by publisher]


Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.
Makoto Uchiyama, Yoshiyuki Nishio, Kayoko Yokoi, Yoshiyuki Hosokai, Atsushi Takeda, Etsuro Mori
Parkinsonism Relat Disord 2015 Mar;
PMID: 25864093 [PubMed - as supplied by publisher]


The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (?-syn) toxicity to rat nigral neurons.
Maxim Salganik, Valeriy G Sergeyev, Vishal Shinde, Craig A Meyers, Marina S Gorbatyuk, Jonathan H Lin, Sergey Zolotukhin, Oleg S Gorbatyuk
Neurobiol Aging 2015 Mar;
PMID: 25863526 [PubMed - as supplied by publisher]


Convergence of parkin, PINK1 and ?-synuclein on stress-induced mitochondrial morphological remodelling.
Kristi L Norris, Rui Hao, Liang-Fu Chen, Chun-Hsiang Lai, Meghan Kapur, Peter J Shaughnessy, Dennis Chou, Jin Yan, J Paul Taylor, Simone Engelender, Anna E West, Kah-Leong Lim, Tso-Pang Yao
J Biol Chem 2015 Apr;
PMID: 25861987 [PubMed - as supplied by publisher]


Mitochondrial dynamism and heart disease: changing shape and shaping change.
Gerald W Dorn
EMBO Mol Med 2015 Apr;
PMID: 25861797 [PubMed - as supplied by publisher]


Prolongation of Chemically-Induced Methemoglobinemia in Mice Lacking ?-synuclein: A Novel Pharmacologic and Toxicologic Phenotype.
Yien-Ming Kuo, Robert L Nussbaum
Toxicol Rep 2015; 2:504-511
PMID: 25859428 [PubMed - as supplied by publisher]


Mitophagy and the mitochondrial unfolded protein response in neurodegeneration and bacterial infection.
Mark W Pellegrino, Cole M Haynes
BMC Biol 2015 ; 13(1):22
PMID: 25857750 [PubMed - as supplied by publisher]


Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease.
Hiromi Sano, Miho Murata, Atsushi Nambu
J Neurochem 2015 Apr;
PMID: 25857446 [PubMed - as supplied by publisher]


Ferulic acid pretreatment mitigates MPTP-induced motor impairment and histopathological alterations in C57BL/6 mice.
Sangeetha Nagarajan, David Raj Chellappan, Prabu Chinnaswamy, Senthilkumar Thulasingam
Pharm Biol 2015 Apr; :1-11
PMID: 25857436 [PubMed - as supplied by publisher]


Neuroprotective effects of alkaloids from Piper longum in a MPTP-induced mouse model of Parkinson's disease.
Ying Bi, Peng-Cheng Qu, Qing-Song Wang, Li Zheng, Hao-Long Liu, Rong Luo, Xiao-Qing Chen, Yin-Ying Ba, Xia Wu, Hui Yang
Pharm Biol 2015 Apr; :1-9
PMID: 25857256 [PubMed - as supplied by publisher]


Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.
Gerwyn Morris, Michael Berk, Ken Walder, Michael Maes
BMC Med 2015 ; 13:28
PMID: 25856766 [PubMed - as supplied by publisher]


Role of the unfolded protein response in the pathogenesis of Parkinson's disease.
Deeksha Varma, Dwaipayan Sen
Acta Neurobiol Exp (Wars) 2015 ; 75(1):1-26
PMID: 25856519 [PubMed - as supplied by publisher]


Small Peptide Inhibitor of JNK3 Protects Dopaminergic Neurons from MPTP Induced Injury via Inhibiting the ASK1-JNK3 Signaling Pathway.
Jing Pan, Hui Li, Bei Zhang, Ran Xiong, Yu Zhang, Wen-Yan Kang, Wei Chen, Zong-Bo Zhao, Sheng-Di Chen
PLoS One 2015 ; 10(4):e0119204
PMID: 25856433 [PubMed - as supplied by publisher]


?-Synuclein-Independent Histopathological and Motor Deficits in Mice Lacking the Endolysosomal Parkinsonism Protein Atp13a2.
Lauren R Kett, Barbara Stiller, Megan M Bernath, Inmaculada Tasset, Javier Blesa, Vernice Jackson-Lewis, Robin B Chan, Bowen Zhou, Gilbert Di Paolo, Serge Przedborski, Ana Maria Cuervo, William T Dauer
J Neurosci 2015 Apr; 35(14):5724-42
PMID: 25855184 [PubMed - as supplied by publisher]


E-health Support in People with Parkinson's Disease with Smart Glasses: A Survey of User Requirements and Expectations in the Netherlands.
Yan Zhao, Tjitske Heida, Erwin E H van Wegen, Bastiaan R Bloem, Richard J A van Wezel
J Parkinsons Dis 2015 Apr;
PMID: 25855044 [PubMed - as supplied by publisher]


Minimal change multiple system atrophy: An aggressive variant?
Helen Ling, Yasmine T Asi, Igor N Petrovic, Zeshan Ahmed, L K Prashanth, Lili-Naz Hazrati, Masatoyo Nishizawa, Tetsutaro Ozawa, Anthony Lang, Andrew J Lees, Tamas Revesz, Janice L Holton
Mov Disord 2015 Apr;
PMID: 25854893 [PubMed - as supplied by publisher]


Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate.
Petranka Krumova, Lauran Reyniers, Marc Meyer, Evy Lobbestael, Daniela Stauffer, Bertran Gerrits, Lionel Muller, Sjouke Hoving, Klemens Kaupmann, Johannes Voshol, Doriano Fabbro, Andreas Bauer, Giorgio Rovelli, Jean-Marc Taymans, Tewis Bouwmeester, Veerle Baekelandt
FASEB J 2015 Apr;
PMID: 25854701 [PubMed - as supplied by publisher]


PGC-1? activity in nigral dopamine neurons determines vulnerability to ?-synuclein.
Carine Ciron, Lu Zheng, Wojciech Bobela, Graham W Knott, Teresa C Leone, Daniel P Kelly, Bernard L Schneider
Acta Neuropathol Commun 2015 ; 3(1):16
PMID: 25853296 [PubMed - as supplied by publisher]